Neuralink for Speech Restoration
If you're interested in participating in our clinical trials for speech restoration, join our Patient Registry.
VOICE
ClinicalTrials.gov ID: NCT07224256
What is the VOICE Study investigating?
The N1 Implant, which is an investigational brain-computer interface designed to help people with severe speech impairment output verbal thought as text or directly to speech.
Has anyone used the N1 Implant before?
Yes. The first participant received their Neuralink implant in January 2024.
Since then, multiple ALS and spinal cord injury participants have received the N1 Implant.
Who may be eligible?
We are looking for individuals who:
- Have severe speech impairment and impaired upper limb function due to:
- Amyotrophic lateral sclerosis (ALS)
- Primary lateral sclerosis (PLS)
- Spinal cord injury
- Stroke
- Are at least 22 years old
- Have a consistent and reliable caregiver
Study Sites
- The University of Texas Southwestern Medical Center
If you or someone you love is interested in learning more about Neuralink’s clinical trials, we encourage you to join our Patient Registry.
How it works
When a person communicates through spoken language, there are certain areas of the brain that become activated and generate signals that are routed to the muscles of the mouth, tongue, and voice box.
Neurological conditions such as cerebral palsy, stroke, multiple sclerosis, spinal cord injury, and amyotrophic lateral sclerosis may impair or prevent these brain signals from resulting in intelligible speech.
Brain-computer interfaces (BCIs) that can record and decode these cortically generated brain signals have the potential to turn thought into speech or text.
At Neuralink, we are developing implanted BCI technology to enable people with speech disorders to communicate again.